medtech
(88)
Haley Chute Is Building Healthcare AI Around Its Scarcest Ingredient: Trust
The biomedical engineer turned product-and-marketing chief has a plain test for clinical AI: help people see what matters, keep the clinician in charge, and earn trust one conversation at a time.
Matt Kaufman Learned the Rules - Then Built a Career Making Complicated Things Clear
A lawyer by training and a builder by temperament, Matt Kaufman has spent two decades translating regulated, technical businesses into stories people can understand - and teams can act on.
Brian Katzman Made Lost Keys Obvious. Now He’s Making Compliance Legible.
A career that began with AdWords and helped turn Tile into a household shorthand now faces a less cuddly brief: explain why the paperwork around safety-critical software should move as quickly as the code.
Garrett Schwab Is Building for the Long Wait Between Idea and Impact
The XII Medical CEO has spent a career in the unglamorous middle of medical invention - where patents, payment, teams and patient access must eventually agree.
Michael Favet Keeps Choosing the Hard Part of Medtech
After helping take NeuroPace public, the engineer-turned-operator returned to a small clinical-stage company. His career makes a case for learning every room before taking the corner office.
Karun Naga Left Patent Law to Build What the Patents Promised
His route from Michigan engineering classrooms to a $130 million clinical-stage company is a study in useful detours, patient capital and the discipline to stop doing everything at once.
Nitin Salunke’s One-Risk-at-a-Time Playbook
The Supira Medical CEO built his career by translating biomechanics into products, then learned to run a startup by staging risk, keeping options open and making clinical data do the talking.
Mary Beth Moynihan Built a Career by Working Backward
For nearly three decades at Boston Scientific, Mary Beth Moynihan has treated a career less like a ladder than a design problem: name the destination, map the missing experiences and make the next move count.
Erez Kaminski Is Making Compliance Move at Software Speed
The physicist-turned-founder built Ketryx around a stubborn idea: the paperwork surrounding safety-critical software should update as quickly and carefully as the code itself.
Bill Hunter Put a Voice Inside the Implant
A physician-founder spent three decades teaching medical hardware to do more than sit quietly. His latest chapter turns implants into long-lived witnesses, sending useful signals from inside the body.
Ann Fyfe Built the Room Where Medtech Ideas Met Reality
Before accelerators became a Silicon Valley reflex, Ann Fyfe helped put one inside a community hospital - then built the partnerships that let fragile medical-device ideas meet clinicians, regulators and reality.
Andrew Cleeland Is Building a Place Where Experience Compounds
After two major startup exits, Andrew Cleeland chose a different kind of scale: helping generations of medtech builders turn hard-won experience into a shared advantage.
Amr Salahieh Built a Factory for Starting Companies
He kept losing time to leases, hiring and infrastructure. So the engineer behind Shifamed designed those distractions out - and turned one company-building career into a repeatable system.
The Person Selling Certainty in a Business Built on Doubt
A marketing job at a company whose products live or die on trust, sold to buyers who read the footnotes. Here is what that work looks like from the inside.
Stacie Arechavala
Stacie Arechavala is a biomedical engineer and the cofounder and CEO of Selera Medical (YC W24), a San Francisco medical device startup she started in 2023 with Kevin Bui after the two met as fellows at Stanford Biodesign. She trained at the University of Miami and Duke, developed cardiovascular devices at Medtronic, and built low-cost devices for underserved communities before turning her attention to heart failure care. Her guiding line: innovation can change the world, but design is what makes it happen.
Shreya Mehta
Shreya Mehta is the President and CEO of Zenflow, a South San Francisco medical device company she co-founded in 2014 out of the Stanford Biodesign Innovation Fellowship. A biomedical engineer and former FDA reviewer, she spent a decade building the Zenflow Spring System, a minimally invasive, reversible implant that props open the urethra to relieve symptoms of benign prostatic hyperplasia (BPH). She started as CTO before stepping into the CEO seat, closed a $24M Series C in November 2024, and helped guide the company to FDA approval.
Ted Belleza
Ted Belleza is the founder, President and CEO of URO-1, Inc., a medical device company based in Greensboro, North Carolina that develops the SUREcore biopsy needle and coreCARE specimen-retrieval kit for prostate and soft tissue biopsy. A serial MedTech entrepreneur with more than 35 years of business experience and prior roles at Gynesonics (acquired by Hologic), Endosee (acquired by CooperSurgical) and LiveLeaf Bioscience, Belleza came out of retirement after his own prostate cancer experience to redesign what he calls an antiquated biopsy procedure, aiming to give physicians bigger, better and more consistent tissue samples.
Tracy MacNeal
Tracy MacNeal is a chemical engineer turned healthcare executive who serves as President and CEO of Materna Medical, a women's health technology company in Mountain View, California. With more than 25 years across pharmaceuticals, diagnostics, digital health and medical devices, and six transactions to her name, she has built a career on commercializing hard-to-define products and opening markets that others overlook. She sits on the board of AdvaMed and chairs its Women's Executive Network, and she is known for pairing engineering rigor with a storyteller's instinct for building trust with clinicians, investors and customers.
Daniel Wagner
Daniel (Dan) Wagner is a medical device and biotechnology executive who leads Otolith Labs, the Washington, DC company building the OtoBand, a non-invasive wearable that uses patented non-invasive Vestibular Resonance Therapy (nVRT) to address chronic vertigo. With more than two decades of commercial experience spanning 60-plus countries and roles at Spark Biomedical, Olympus Corporation, HeartSciences and Signature Biologics, Wagner advised Otolith for over five years before joining full-time as Chief Commercial Officer in 2024 and now serves as Chief Executive Officer, steering the company's go-to-market strategy toward a planned market launch.
Eric Gornstein
Eric Gornstein is the Chief Executive Officer of Pearl Diagnostics, a Johns Hopkins spinout in Baltimore that makes MycoMEIA, the first FDA-cleared urine test for invasive aspergillosis. A biopharma commercialization veteran with more than 25 years leading product launches, partnering and deal-making across therapeutic areas, he joined Pearl in late 2025 to take the company from FDA clearance to the market and into Europe. Earlier he helped launch Radius Health's first product, Tymlos, and worked in business development and cell therapy partnerships at companies including bit.bio and Talaris Therapeutics.
Gabriel Jones
Gabriel Jones is the co-founder and CEO of Proprio, a Seattle medtech company building AI-powered surgical navigation. Its FDA-cleared Paradigm platform combines light-field imaging, real-time AI, and 3D visualization to give surgeons dynamic spatial awareness during spine procedures. Jones took an unusual path to medtech - engineering study in Japan, civil engineering at Taisei, Wall Street M&A, and work with the Bill & Melinda Gates Foundation - before co-founding Proprio in 2016 with a neurosurgeon, a robotics professor, and a computer vision specialist. He frames the mission around a single question: is it possible to do well and do good?
Galia Rosen Schwarz
Galia Rosen Schwarz is the cofounder and CEO of C8 Health, a New York-based clinical resource management platform that centralizes hospital protocols, guidelines and policies and pushes the right clinical knowledge to the right clinician at the right time. A former researcher and go-to-market leader with a PhD in strategy from the Technion and a visiting professorship at NYU Stern, she has grown C8 Health to more than 100 US hospitals, including leading academic medical centers, on the back of an $18 million total raise.
Howard Rosen
Howard Rosen is the CEO and co-founder of Evident Vascular, a San Jose medtech startup building an AI-powered intravascular ultrasound (IVUS) platform for peripheral and coronary interventions. A 30-year cardiovascular device veteran, he spent 21 years at Boston Scientific before helping guide Intact Vascular and its spinout Vesper Medical through acquisitions by Philips. He launched Evident out of stealth in 2023 with a $35 million Series A led by Vensana Capital and closed a Series B in 2025. He is known for a disciplined 'go slow to go fast' company-building philosophy.
Manisha Shah-Bugaj
Manisha Shah-Bugaj is the CEO of Activ Surgical, a Boston-based medical technology company building hardware-agnostic surgical software and its ActivSight Intelligent Light imaging module. A medtech executive with more than two decades of experience, she previously built Olympus's U.S. gynecology business from the ground up, rising to General Manager and Global Vice President, before joining Activ Surgical as COO in January 2022 and becoming CEO that December.
Michael Monovoukas
Michael Monovoukas is the CEO and co-founder of AcuityMD, a Boston-based commercial intelligence platform for the medical device industry. Founded in 2019, AcuityMD gives medtech sales teams a shared view of physicians, procedures, and referral networks. In April 2026 the company raised an $80M Series C led by StepStone Group, pushing its valuation near $1B and total funding past $160M.
Per Langoe
Per Langoe is the CEO of GT Medical Technologies, the Tempe, Arizona company behind GammaTile, an FDA-cleared radiation therapy tile that gets sewn into the brain the same moment a tumor is removed. He arrived in February 2024 after co-founding and selling Palette Life Sciences to Teleflex for $600 million, bringing more than two decades in radiation oncology commercialization from Pharmacia, Q-Med, Galderma and Nestle Skin Health.
Wendelin Maners
Wendelin Maners is the President and CEO of CSA Medical, the Lexington, Massachusetts medical-device company behind the RejuvenAir System, a liquid-nitrogen cryospray technology delivered by bronchoscope. A finance-trained dealmaker who spent years buying and licensing emerging technologies for Boston Scientific, Maners moved from the deal table to the operating chair, taking the top job at CSA Medical in December 2019 and steering the company through an oversubscribed $53 million Series D and a fully enrolled pivotal trial on the road to FDA approval.
Anuj Bhardwaj
Anuj Bhardwaj is the co-founder and CEO of SecondWave Systems, a Minneapolis-St. Paul medical device company building the SecondWave MINI, a wearable, noninvasive ultrasound device that aims to calm chronic inflammation by aiming focused sound at the spleen. He took a family-owned industrial ultrasound business founded by his parents in 1977 and redirected its core technology toward medicine, raising a $7M Series A in 2025 on top of more than $15M in government research funding from DARPA, NIH, and ARPA-H. Trained as a mechanical engineer at Penn State with an MS and MBA from MIT, he sits at the crossroads of hardware, bioelectronic medicine, and the emerging field of bio-ultrasonic therapy.
Konrad Morzkowski
Konrad Morzkowski is the Swedish-born co-founder and CEO of WearLinq, a San Francisco medtech company commercializing eWave, an FDA-cleared 6-lead wireless ECG monitor that ships heart data from a patch on the chest to a smartphone in your pocket. A Chalmers and Stanford engineer named to Forbes' 30 Under 30 in Healthcare (2024), he traded a plan to build AI for healthcare for the harder problem of getting clinical-grade cardiology out of the hospital and onto the patient.
Aram Hong
Aram Hong is the CEO and co-founder of Apollon, a Seoul-born, Cambridge-based medtech company building MOGLU, a needle-free continuous glucose monitor powered by Raman spectroscopy. A former EY advisor and Genoplan executive who moved his family from Seoul to Boston to scale the company alongside MIT researchers, Hong has turned a laser-and-optics idea into a CES 2025 Innovation Award honoree that, in peer-reviewed clinical testing, matched the accuracy of leading needle-based sensors from Abbott and Dexcom.